关于 Tikcro technologies

关于公司

Tikcro develops and distributes biotechnology technologies for its clients. The company’s early stage pipeline consists of CTLA-4 antibody, PD1, antibody, PDL1, PDL2, and TIGIT. Furthermore, it develops and distributes 3D antigen design technologies that generates functional antibodies for its clients. Tikcro was founded in 1999 and is based in Ra’anana.